Jeffrey Davis
Founder bei SCO Securities LLC
Profil
Jeffrey Blaine Davis is the founder of SCO Securities LLC, founded in 1997, where he holds the title of President.
He is also the founder of SCO Financial Group LLC, founded in 1997.
Currently, Mr. Davis is the Chief Executive Officer & Director at Varian Biopharma, Inc. and a Partner at SCO Capital Partners LLC, starting in 2003.
Mr. Davis has previously worked as the President, Chief Executive Officer & Director at Varian Biopharmaceuticals, Inc. He was also a Director at MacroChem Corp.
from 2005 to 2009.
Additionally, he served as a Director at Bioenvision, Inc., Oxford Ventures, Inc., ULURU, Inc., and Virium Pharmaceuticals, Inc. From 2017 to 2018, he was the Chief Operating Officer at Abeona Therapeutics, Inc. He has also held positions at Deutsche Bank AG, HMSR, Inc., Deutsche Morgan Grenfell, Bell Laboratories, and Philips Medical Systems North America, Inc.Mr. Davis holds an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Boston University College of Engineering.
Aktive Positionen von Jeffrey Davis
| Unternehmen | Position | Beginn |
|---|---|---|
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Private Equity Investor | 04.11.2010 |
| SCO Securities LLC | Founder | 29.07.2011 |
Ehemalige bekannte Positionen von Jeffrey Davis
| Unternehmen | Position | Ende |
|---|---|---|
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Chief Executive Officer | 01.11.2022 |
| ABEONA THERAPEUTICS INC. | Chief Executive Officer | 19.09.2014 |
| ULURU INC. | Director/Board Member | 01.12.2015 |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Director/Board Member | 26.02.2009 |
| Oxford Ventures, Inc. | Director/Board Member | 05.04.2006 |
Ausbildung von Jeffrey Davis
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Boston University College of Engineering | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| DEUTSCHE BANK AG | Finance |
| ULURU INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Health Technology |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
| Oxford Ventures, Inc. | Health Technology |
SCO Capital Partners LLC
SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Finance |
| SCO Securities LLC | |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance SCO Financial Group LLC operates a full service merchant bank, which is engaged in providing services to life sciences companies. It also offers fund management, investment banking and corporate partnering and licensing services to healthcare companies. The company was founded in 1997 and is headquartered in New York, NY. | Finance |
HMSR, Inc.
 HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Health Technology |
| Deutsche Morgan Grenfell | Finance |
Bell Laboratories
 Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Bell Laboratories provides research and development services. It provides communications technologies including transistors, digital networking, signal processing, lasers and fiber-optic communications systems, communication satellites, cellular telephony, electronic switching of calls, touch-tone dialing and modems. The company was founded in 1925 and is headquartered in Murray Hill, NJ. | Commercial Services |
Virium Pharmaceuticals, Inc.
 Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Health Technology |
Philips Medical Systems North America, Inc.
 Philips Medical Systems North America, Inc. Medical SpecialtiesHealth Technology Part of Koninklijke Philips NV, Philips Medical Systems North America, Inc. is a private company that manufactures and wholesales diagnostic imaging systems and devices. The company is based in Bothell, WA. | Health Technology |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Health Technology |
